Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in CAI — Caris Life Sciences, Inc.

CIK 1446194 BALA CYNWYD, PA

Position in CAI

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,642,978
+$2,694,158 QoQ
Shares Held
204,432
+285.2% QoQ
Ownership
0.072%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#56
of 246 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CAI Over Time

Shares Held

Position Value (USD)

Derivatives in CAI

reported options exposure · as of Jun 30, 2026
CallValue
$3,719,034
CallShares
208,700
PutValue
$2,811,996
PutShares
157,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,649,997,309 across 349 Biotechnology names. CAI ranks #59 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CAI

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,811,996 157,800
2026-06-30 $3,642,978 204,432
2026-06-30 $3,719,034 208,700
2026-03-31 $2,918,016 163,200
2026-03-31 $948,820 53,066
2026-03-31 $1,904,220 106,500
2025-12-31 $3,180,942 117,900
2025-12-31 $1,208,704 44,800
2025-09-30 $1,046,650 34,600
2025-09-30 $4,398,350 145,400
2025-09-30 $876,887 28,988
2025-06-30 $285,904 10,700